Purchases and Sales Made in Q4 2022 in Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT) during Q4 2022. The information is specifically focused on institutions that hold shares of EyePoint Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-5.61K- 2.68% |
$13.3K - $40.4K
|
204K
$1.77M
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-7.23K- 6.27% |
$17.1K - $52.1K
|
108K
$941K
|
|
Feb 14, 2023
Q4 2022
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-9.02K- 1.6% |
$21.4K - $64.9K
|
556K
$4.83M
|
|
Feb 14, 2023
Q4 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-21.8K- 44.6% |
$51.6K - $157K
|
27K
$235K
|
|
Feb 07, 2023
Q4 2022
|
Lincoln National Corp
|
SELL
|
- |
-21.8K- 55.79% |
$51.6K - $157K
|
17.3K
$150K
|
|
Feb 09, 2023
Q4 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-29.8K- 32.3% |
$70.7K - $215K
|
62.6K
$544K
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-89.9K- 10.54% |
$213K - $647K
|
763K
$6.64M
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-89.9K- 10.54% |
$213K - $647K
|
763K
$6.64M
|
|
Feb 02, 2023
Q4 2022
|
Essex Investment Management CO LLC
Boston, MA |
SELL
|
- |
-140K- 40.99% |
$332K - $1.01M
|
202K
$1.76M
|
|
Feb 14, 2023
Q4 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-483K- 49.77% |
$1.15M - $3.48M
|
488K
$4.24M
|